Multiparameter FLAER-based flow cytometry for screening of paroxysmal nocturnal hemoglobinuria enhances detection rates in patients with aplastic anemia Man Updesh Singh SachdevaNeelam VarmaSubhash Varma Original Article 04 December 2014 Pages: 721 - 728
Efficacy of porcine antihuman lymphocyte immunoglobulin compared to rabbit antithymocyte immunoglobulin as a first-line treatment against acquired severe aplastic anemia Limin LiuLi DingDepei Wu Original Article 22 January 2015 Pages: 729 - 737
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia Hawk KimWon-Sik LeeCoOperative Study Group A for Hematology (COSAH) Original Article 13 December 2014 Pages: 739 - 746
Comparison and evaluation of three screening tests of hereditary spherocytosis in Chinese patients Yi-feng TaoZeng-fu DengFa-quan Lin Original Article 12 December 2014 Pages: 747 - 751
Splenectomy as a treatment for adults with relapsed hemophagocytic lymphohistiocytosis of unknown cause Wang Jing-ShiWang Yi-NiWang Zhao Original Article 16 December 2014 Pages: 753 - 760
WPSS is a strong prognostic indicator for clinical outcome of allogeneic transplant for myelodysplastic syndrome in Southeast Asian patients Liyuan MaSiguo HaoYeh-Ching Linn Original Article 18 December 2014 Pages: 761 - 769
An increase in hemoglobin, platelets and white blood cells levels by iron chelation as single treatment in multitransfused patients with myelodysplastic syndromes: clinical evidences and possible biological mechanisms Massimo BrecciaMaria Teresa VosoGiuliana Alimena Review Article 07 March 2015 Pages: 771 - 777
Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications Ángel F. RemachaBeatriz ArrizabalagaOn behalf of the IRON-2 Study Group Original Article 18 December 2014 Pages: 779 - 787
The JAK2 46/1 haplotype does not predispose to CALR-mutated myeloproliferative neoplasms G. SolerA. Bernal-VicenteF. Ferrer-Marin Original Article 09 December 2014 Pages: 789 - 794
Monosomal karyotype in acute myeloid leukemia and the role of allogeneic hematopoietic cell transplantation Yunsuk ChoiJe-Hwan LeeKyoo-Hyung Lee Original Article 07 January 2015 Pages: 795 - 801
Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy Jordina RoviraAlexandra ValeraArmando López-Guillermo Original Article Open access 14 December 2014 Pages: 803 - 812
Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab N. L. BerinsteinS. BhellaR. Buckstein Original Article 08 January 2015 Pages: 813 - 823
Patterns of monocyte subpopulations and their surface expression of HLA-DR during adverse events after hematopoietic stem cell transplantation Michaela DöringKarin Melanie Cabanillas StanchiGunter Kerst Original Article 30 December 2014 Pages: 825 - 836
Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation Xiaohui ZhangYi ZhouXiaojun Huang Original Article 16 December 2014 Pages: 837 - 845
Applicability of the EORTC/MSG criteria for IFD in clinical practice H. RiegerD. LustigChristina T. Rieger Original Article 30 December 2014 Pages: 847 - 855
Association between early peak temperature and mortality in neutropenic sepsis Robert WeinkoveMichael BaileyPaul J. Young Original Article 18 December 2014 Pages: 857 - 864
A report on the co-occurrence of JAK2V617F and CALR mutations in myeloproliferative neoplasm patients Na XuLi DingXiao-li Liu Letter to the Editor 05 November 2014 Pages: 865 - 867
Calreticulin mutations are not present in patients with myeloproliferative chronic myelomonocytic leukemia Lurdes ZamoraUlrich GermingBlanca Xicoy Letter to the Editor 22 November 2014 Pages: 869 - 871
Clinical factors predictive of myelofibrotic evolution in patients with polycythemia vera Mario TiribelliDaniela BarracoRenato Fanin Letter to the Editor 20 November 2014 Pages: 873 - 874
Alpha thalassemia trait masquerading as hemoglobin H disease due to co-existing primary myelofibrosis Chi-Chiu SoAmy Y. ChanEdmond S. Ma Letter to the Editor 03 December 2014 Pages: 875 - 877
Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib Emanuele AmmatunaMatthias EeftingIvo P. Touw Letter to the Editor 11 December 2014 Pages: 879 - 880
Molecular analyses in the diagnosis of myeloproliferative neoplasm-related splanchnic vein thrombosis Alessandra IurloDaniele CattaneoAgostino Cortelezzi Letter to the Editor 08 November 2014 Pages: 881 - 882
Effect of cytosine arabinoside metabolizing enzyme expression on drug toxicity in acute myeloid leukemia Ajay AbrahamAnup J. DevasiaVikram Mathews Letter to the Editor 13 November 2014 Pages: 883 - 885
Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplant Hui-Ching WangYi-Chang LiuTa-Chih Liu Letter to the Editor 20 December 2014 Pages: 887 - 888
Mutational analysis of oncogenic CSF3R p.T618I in acute leukemias and common solid cancers Sun Yong HwangMyung Shin KimSug Hyung Lee Letter to the Editor 18 November 2014 Pages: 889 - 890
Successful re-administration of lenalidomide after lenalidomide-induced pulmonary alveolar hemorrhage in a patient with refractory myeloma Mizu SakaiTetsuya KubotaAkihito Yokoyama Letter to the Editor 20 November 2014 Pages: 891 - 892
Paraneoplastic pyoderma gangrenosum with posttransplant lymphoproliferative disorder Urvi ShahAthena KritharisAndrew M. Evens Letter to the Editor 18 December 2014 Pages: 893 - 894
Remission induction with lenalidomide in a patient with relapsed diffuse large B cell lymphoma of the leg type Abhisek SwaikaDavid M. MenkeTaimur Sher Letter to the Editor 15 November 2014 Pages: 895 - 896
Symptomatic striopallidodentate calcinosis (Fahr’s syndrome) in a thalassemic patient with hypoparathyroidism Georgios KoutsisGeorgia KaradimaMarios Panas Letter to the Editor 08 November 2014 Pages: 897 - 899